30 May 2012
Researchers based in the UK are confident that a newly-discovered protein could allow for more enhanced prostate cancer treatments to be established.
Scientists at the University of Liverpool have been successful in finding two versions of the PKCZ protein, one of which is deemed 'normal' in appearance and an alternative which is only made in prostate cancer cells.
On top of this discovery, the researchers also pinpointed that this new protein is created using the PRKCZ gene – a sequence which has the potential to influence the behaviour of the life-threatening disease.
Study author Chris Foster, a professor at the University of Liverpool, pointed out: "We now need to discover what role this protein is playing in prostate cancer. If it encourages aggressiveness in the disease then we may be able to develop new drugs that reduce its effects."
People worried about prostate cancer should watch out for common symptoms including the constant need to rush to the toilet to pass urine, pain or difficulty when passing urine or the discovery of blood in the urine or semen.
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.